Nautilus Biotechnology, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2021 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Nautilus Biotechnology, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2021 to Q3 2024.
  • Nautilus Biotechnology, Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 24, 2024 was 126M shares, a 0.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 126M +618K +0.5% Oct 24, 2024 10-Q 2024-10-29
Q2 2024 125M +480K +0.38% Jul 25, 2024 10-Q 2024-07-30
Q1 2024 125M +399K +0.32% Apr 25, 2024 10-Q 2024-04-30
Q3 2023 125M +222K +0.18% Oct 27, 2023 10-Q 2023-10-31
Q2 2023 125M +268K +0.22% Jul 31, 2023 10-Q 2023-08-02
Q1 2023 125M +405K +0.33% Apr 27, 2023 10-Q 2023-05-02
Q4 2022 125M +440K +0.35% Jan 31, 2023 10-K 2023-02-23
Q3 2022 125M +557K +0.45% Oct 28, 2022 10-Q 2022-11-01
Q2 2022 125M +569K +0.46% Jul 29, 2022 10-Q 2022-08-02
Q1 2022 124M Apr 29, 2022 10-Q 2022-05-03
Q4 2021 124M Jan 31, 2022 10-K 2022-02-24
Q3 2021 124M Oct 31, 2021 10-Q 2021-11-02
Q2 2021 124M Jul 31, 2021 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.